+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharming Group NV - logo

The Pharming Group offers novel platforms for the production of protein therapeutics, as well as processes for the purification and formulation. The company’s best known product is Ruconest, a human C1 inhibitor. Human C1 inhibitor is a protein involved in the regulation of the complement and contact pathways of the immune system. Pharming Group N.V. is headquartered in Leiden, the Netherlands.

Fibrin Sealant Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Fibrin Sealant Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • April 2023
  • 100 Pages
  • Global
From
Plasma Protease C1-inhibitor Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Plasma Protease C1-inhibitor Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 78 Pages
  • Global
From
Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 589 Pages
  • Global
From
Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 580 Pages
  • Global
From
Alpha Galactosidase A Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Alpha Galactosidase A Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 105 Pages
  • Global
From
Pompe Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Pompe Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 94 Pages
  • Global
From
Fabry Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Fabry Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 102 Pages
  • Global
From
Immunologic Deficiency Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Immunologic Deficiency Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Complement C1s inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Complement C1s inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Licensing Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2019-2024

  • Report
  • March 2024
  • 1300 Pages
  • Global
From
Distribution Deals in Pharmaceuticals and Biotechnology 2016 to 2024 - Product Thumbnail Image

Distribution Deals in Pharmaceuticals and Biotechnology 2016 to 2024

  • Report
  • March 2024
  • 500 Pages
  • Global
From
Hemophilia A - Pipeline Review, H2 2019 - Product Thumbnail Image

Hemophilia A - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 212 Pages
  • Global
From
Contrast Induced Nephropathy (Genitourinary Disorders) - Drugs In Development, 2021 - Product Thumbnail Image

Contrast Induced Nephropathy (Genitourinary Disorders) - Drugs In Development, 2021

  • Drug Pipelines
  • June 2021
  • 46 Pages
  • Global
From
Acute Renal Failure (ARF) (Acute Kidney Injury) (Genitourinary Disorders) - Drugs in Development, 2021 - Product Thumbnail Image

Acute Renal Failure (ARF) (Acute Kidney Injury) (Genitourinary Disorders) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Collaboration Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2019-2024

  • Report
  • March 2024
  • 1000 Pages
  • Global
From
Acute Respiratory Distress Syndrome (Respiratory) - Drugs in Development, 2021 - Product Thumbnail Image

Acute Respiratory Distress Syndrome (Respiratory) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024 - Product Thumbnail Image

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024

  • Report
  • March 2024
  • 700 Pages
  • Global
From
Ischemia Reperfusion Injury (Cardiovascular) - Drugs in Development, 2021 - Product Thumbnail Image

Ischemia Reperfusion Injury (Cardiovascular) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Lactoferrin Market - Global Industry Size, Share, Trends Opportunity, and Forecast 2018-2028 - Product Thumbnail Image

Lactoferrin Market - Global Industry Size, Share, Trends Opportunity, and Forecast 2018-2028

  • Report
  • October 2023
  • 190 Pages
  • Global
From
Lactoferrin Market Size, Share & Trends Analysis Report by Function (Iron Absorption, Intestinal Flora Protection), by Application (Personal Care Products, Infant Formula), by Region (North America, APAC, Europe), and Segment Forecasts, 2021-2028 - Product Thumbnail Image

Lactoferrin Market Size, Share & Trends Analysis Report by Function (Iron Absorption, Intestinal Flora Protection), by Application (Personal Care Products, Infant Formula), by Region (North America, APAC, Europe), and Segment Forecasts, 2021-2028

  • Report
  • February 2022
  • 125 Pages
  • Global
From
Loading Indicator